Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-46.75%
Price
09.05.24
€14.59
Summary
This prediction is currently active. Massive losses of -46.75% have been the result for the BUY prediction by Morgan_Stanley. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -6.564% | -6.564% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-15.66%
09.05.24
09.05.24